Cargando…

The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)

Since 2004, fish oil based lipid emulsions have been used in the treatment of intestinal failure associated liver disease, with a noticeable impact on decreasing the incidence of morbidity and mortality of this often fatal condition. With this new therapy, however, different approaches have emerged...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Melissa I., Puder, Mark, Gura, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546610/
https://www.ncbi.nlm.nih.gov/pubmed/23363993
http://dx.doi.org/10.3390/nu4121828
_version_ 1782256072743976960
author Chang, Melissa I.
Puder, Mark
Gura, Kathleen M.
author_facet Chang, Melissa I.
Puder, Mark
Gura, Kathleen M.
author_sort Chang, Melissa I.
collection PubMed
description Since 2004, fish oil based lipid emulsions have been used in the treatment of intestinal failure associated liver disease, with a noticeable impact on decreasing the incidence of morbidity and mortality of this often fatal condition. With this new therapy, however, different approaches have emerged as well as concerns about potential risks with using fish oil as a monotherapy. This review will discuss the experience to date with this lipid emulsion along with the rational for its use, controversies and concerns.
format Online
Article
Text
id pubmed-3546610
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-35466102013-01-23 The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD) Chang, Melissa I. Puder, Mark Gura, Kathleen M. Nutrients Review Since 2004, fish oil based lipid emulsions have been used in the treatment of intestinal failure associated liver disease, with a noticeable impact on decreasing the incidence of morbidity and mortality of this often fatal condition. With this new therapy, however, different approaches have emerged as well as concerns about potential risks with using fish oil as a monotherapy. This review will discuss the experience to date with this lipid emulsion along with the rational for its use, controversies and concerns. MDPI 2012-11-27 /pmc/articles/PMC3546610/ /pubmed/23363993 http://dx.doi.org/10.3390/nu4121828 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Chang, Melissa I.
Puder, Mark
Gura, Kathleen M.
The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)
title The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)
title_full The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)
title_fullStr The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)
title_full_unstemmed The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)
title_short The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)
title_sort use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (ifald)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546610/
https://www.ncbi.nlm.nih.gov/pubmed/23363993
http://dx.doi.org/10.3390/nu4121828
work_keys_str_mv AT changmelissai theuseoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald
AT pudermark theuseoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald
AT gurakathleenm theuseoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald
AT changmelissai useoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald
AT pudermark useoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald
AT gurakathleenm useoffishoillipidemulsioninthetreatmentofintestinalfailureassociatedliverdiseaseifald